Hospital pharmacy tech one of first in Ontario to provide COVID-19 vaccine Long COVID: Who is at risk? Renal replacement therapy because of kidney failure rate rising 1.6% annually U.S. FDA recommends avoiding use of NSAIDs in pregnancy at 20 weeks or later U.S. FDA recommends avoiding use of NSAIDs in pregnancy at 20 weeks or later NSAIDs may cause rare kidney problems in unborn babies and/or low levels of amniotic fluid. Risk of cardiovascular events with SGLT2 inhibitors versus DPP-4 inhibitors Canadian researchers compare the “real world” risk of cardiovascular events with SGLT2 inhibitors and DPP-4 inhibitors in type 2 diabetes. Canada doesn’t have enough doctors to manage our post-COVID-19 patients An opt-out organ donor system could address Canada’s shortage of organs for transplant Better hypertension management: How to work with patients for improved BP results How to work with patients for improved blood pressure results US FDA removes boxed warning about risk of leg/foot amputations with canagliflozin Healthcare professionals and patients should continue to monitor for new pain, tenderness, sores, ulcers and infections in the legs and feet Should we artificially promote the use of biosimilar drugs in Canada? There is much to debate in the question of whether or not biosimilars should be promoted as an alternative to biologic medicines. First Previous 19 20 21 22 23 Next Last
